Amanda Rojek, MBBS, Prof Peter Horby, FRCP, Dr Jake Dunning, MRCP 

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Volume 350, Issue 9071, Pages (July 1997)
Chee-Seng Tan, MRCP, David Gilligan, FRCPE, Dr Simon Pacey, FRCP 
Volume 390, Issue 10098, Pages (September 2017)
Volume 357, Issue 9273, Pages (June 2001)
ZIKA App – A great resource from the World Health Organization (WHO)
Antimicrobial therapy to prevent or treat oral mucositis
Volume 6, Issue 7, Pages (July 2005)
Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis 
Volume 359, Issue 9322, Pages (June 2002)
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review  X.-F. Gao, Z.-W. Yang, J. Li  International.
Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa  Prof Tonya Renee Thurman,
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?  Dr Simone Lanini, MD, Prof Alimuddin.
Thank God for Richard Dawkins?
Volume 10, Issue 12, Pages (December 2011)
Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis  Katharina Kranzer,
Brian J Coburn, David J Gerberry, Sally Blower 
Helen Cox, Mark P Nicol  The Lancet Infectious Diseases 
Meta-analysis of randomised controlled trials
The Ebola suspect's dilemma
Controlling Ebola: key role of Ebola treatment centres
Infections related to totally implantable venous-access ports
Volume 371, Issue 9611, Pages (February 2008)
John N Nkengasong, Philip Onyebujoh  The Lancet 
Volume 9, Issue 12, Pages (December 2010)
Ebola virus epidemic in war-torn eastern DR Congo
Ebola superspreading The Lancet Infectious Diseases
Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study  Matthew Waxman, MD,
When less is more: how many doses of PCV are enough?
Aspirin in the prevention of cancer – Author's reply
Do air quality alerts benefit public health? New evidence from Canada
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Effective cross-sector collaborations create sustainability
Organisation of the care of patients with heart failure
Until eradication, awareness
Incident diabetes in clinical trials of antihypertensive drugs
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?  Dr Simone Lanini, MD, Prof Alimuddin.
Arnaud Chiolero  The Lancet Public Health 
Anthony Rodgers, Alistair Woodward, Boyd Swinburn, William H Dietz 
Challenges to eliminate rabies virus infection in China by 2020
Malebona Precious Matsoso, Jeanette Rebecca Hunter, Vishal Brijlal 
Modelling the effect of early detection of Ebola
Sequelae of Ebola virus disease: the emergency within the emergency
Community-based care of Ebola virus disease in west Africa
Assessment of herd immunity from human papillomavirus vaccination
What would happen if we stopped vaccination?
Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa  Prof Tonya Renee Thurman,
Sven Pischke, Patrick Behrendt, Michael P Manns, Heiner Wedemeyer 
Telling it like it isn't: truth and lies in a post-9/11 world
Philippe Mayaud, MD, Sarah Hawkes, MB, Professor David Mabey, FRCP 
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial  Dr.
Thank God for Richard Dawkins?
Low-technology approaches
Thank you to our diverse (but not diverse enough) reviewers
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Costs of eliminating HIV in South Africa have been underestimated
GBD 2016 estimates problematic for South Africa
Infections related to totally implantable venous-access ports
Spatial lifecourse epidemiology
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers  Dr Michael Jacobs, FRCP,
A remarkable report card on progress in COPD
Ebola control: rapid diagnostic testing
Refining treatment choices for ADHD
Volume 371, Issue 9611, Pages (February 2008)
The dilemma of vaginal breech delivery worldwide
Symptom-based stratification of autoimmune diseases
Sickle cell disease: a new era
Autism, maths, and sex: the special triangle
Presentation transcript:

Insights from clinical research completed during the west Africa Ebola virus disease epidemic  Amanda Rojek, MBBS, Prof Peter Horby, FRCP, Dr Jake Dunning, MRCP  The Lancet Infectious Diseases  Volume 17, Issue 9, Pages e280-e292 (September 2017) DOI: 10.1016/S1473-3099(17)30234-7 Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure Significant research advances during west Africa Ebola virus disease epidemic Adapted from Bausch and Rojek (2016).134 (A) WHO holds consultation on potential Ebola therapeutics and vaccines.135 (B) WHO Response Team publishes first large observational patient data set.13 (C) Interim results of VSV-ZEBOV vaccine trial published.124 (D) Molecular evidence for sexual transmission published.104 (E) First clinical trial of experimental treatment (convalescent plasma) published.71 The Lancet Infectious Diseases 2017 17, e280-e292DOI: (10.1016/S1473-3099(17)30234-7) Copyright © 2017 Elsevier Ltd Terms and Conditions